The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

This study is currently recruiting participants.

Study NCT00012506. Last updated on June 23, 2005. Information provided by National Eye Institute (NEI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00012506

Locations


United States, Maryland
	National Institutes of Health	Recruiting
	Bethesda, Maryland, United States, 20892
	Contact: Susan H Smith 391-435-4559 smithsmith@intra.nei.nih.gov
	Principal Investigator: Janine A Smith, M.D.

Sponsors and Collaborators

National Eye Institute (NEI)